Your browser doesn't support javascript.
Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn's Disease and Regulated By Microbial and Inflammatory Signaling.
Patankar, Jay Vasant; Chiriac, Mircea Teodor; Lehmann, Malte; Kühl, Anja A; Atreya, Raja; Becker, Christoph; Gonzalez-Acera, Miguel; Schmitt, Heike; Gamez-Belmonte, Reyes; Mahapatro, Mousumi; Diemand, Leonard; Hartmann, Leonie; Mascia, Fabrizio; Hracsko, Zsuzsanna; Thonn, Veronika; Schödel, Lena; Zielinska, Marta; Yu, Yuqiang; Erkert, Lena; Li, Wei; Zeitler, Melanie; Ruder, Barbara; Ganzleben, Ingo; Günther, Claudia; Voehringer, David; Zundler, Sebastian; Neurath, Markus F; Siegmund, Britta.
  • Patankar JV; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Chiriac MT; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Lehmann M; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Berlin, Germany; The Transregio 241 IBDome Consortium, Berlin, Germany.
  • Kühl AA; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Berlin, Germany; The Transregio 241 IBDome Consortium, Berlin, Germany; Chari
  • Atreya R; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany; The Transregio 241 IBDome Consortium, Berlin, Germany; Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany.
  • Becker C; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany; The Transregio 241 IBDome Consortium, Berlin, Germany. Electronic address: christoph.becker@uk-erlangen.de.
  • Gonzalez-Acera M; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Schmitt H; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Gamez-Belmonte R; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Mahapatro M; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Diemand L; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Hartmann L; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Mascia F; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Hracsko Z; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Thonn V; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Schödel L; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Zielinska M; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Lodz, Poland.
  • Yu Y; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Erkert L; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Li W; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany; College of Veterinary Medicine, Northeast Agricultural University, Harbin, People's Republic of China.
  • Zeitler M; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Ruder B; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Ganzleben I; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Günther C; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Voehringer D; Department of Infection Biology, University Hospital Erlangen, Erlangen, Germany.
  • Zundler S; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany; Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany.
  • Neurath MF; Department of Medicine 1, University of Erlangen-Nuremberg, Erlangen, Germany; The Transregio 241 IBDome Consortium, Berlin, Germany; Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany.
  • Siegmund B; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Berlin, Germany; The Transregio 241 IBDome Consortium, Berlin, Germany.
Gastroenterology ; 160(3): 925-928.e4, 2021 02.
Article in English | MEDLINE | ID: covidwho-1575253

Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, Virus / Crohn Disease / Inflammation Mediators / Gastrointestinal Microbiome / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 / COVID-19 / Ileum Type of study: Observational study / Prognostic study Limits: Animals / Humans Language: English Journal: Gastroenterology Year: 2021 Document Type: Article Affiliation country: J.gastro.2020.10.021

Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, Virus / Crohn Disease / Inflammation Mediators / Gastrointestinal Microbiome / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 / COVID-19 / Ileum Type of study: Observational study / Prognostic study Limits: Animals / Humans Language: English Journal: Gastroenterology Year: 2021 Document Type: Article Affiliation country: J.gastro.2020.10.021